217 related articles for article (PubMed ID: 34863842)
1. Localized delivery of immunotherapy via implantable scaffolds for breast cancer treatment.
Hope A; Wade SJ; Aghmesheh M; Vine KL
J Control Release; 2022 Jan; 341():399-413. PubMed ID: 34863842
[TBL] [Abstract][Full Text] [Related]
2. Advances in immunotherapy delivery from implantable and injectable biomaterials.
Leach DG; Young S; Hartgerink JD
Acta Biomater; 2019 Apr; 88():15-31. PubMed ID: 30771535
[TBL] [Abstract][Full Text] [Related]
3. Delivery strategies of cancer immunotherapy: recent advances and future perspectives.
Zhao Z; Zheng L; Chen W; Weng W; Song J; Ji J
J Hematol Oncol; 2019 Nov; 12(1):126. PubMed ID: 31779642
[TBL] [Abstract][Full Text] [Related]
4. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
5. Implantable and Injectable Biomaterial Scaffolds for Cancer Immunotherapy.
Li J; Luo Y; Li B; Xia Y; Wang H; Fu C
Front Bioeng Biotechnol; 2020; 8():612950. PubMed ID: 33330440
[TBL] [Abstract][Full Text] [Related]
6. Biomaterial-Based Sustained-Release Drug Formulations for Localized Cancer Immunotherapy.
Mujahid K; Rana I; Suliman IH; Li Z; Wu J; He H; Nam J
ACS Appl Bio Mater; 2023 Dec; ():. PubMed ID: 38050811
[TBL] [Abstract][Full Text] [Related]
7. Local scaffold-assisted delivery of immunotherapeutic agents for improved cancer immunotherapy.
Shang Q; Dong Y; Su Y; Leslie F; Sun M; Wang F
Adv Drug Deliv Rev; 2022 Jun; 185():114308. PubMed ID: 35472398
[TBL] [Abstract][Full Text] [Related]
8. Biomaterials as Local Niches for Immunomodulation.
Adu-Berchie K; Mooney DJ
Acc Chem Res; 2020 Sep; 53(9):1749-1760. PubMed ID: 32786230
[TBL] [Abstract][Full Text] [Related]
9. Surgery-free injectable macroscale biomaterials for local cancer immunotherapy.
Lei K; Tang L
Biomater Sci; 2019 Feb; 7(3):733-749. PubMed ID: 30637428
[TBL] [Abstract][Full Text] [Related]
10. Injectable Hydrogels as Local Depots at Tumor Sites for Antitumor Immunotherapy and Immune-Based Combination Therapy.
Ma H; He C; Chen X
Macromol Biosci; 2021 Jun; 21(6):e2100039. PubMed ID: 33818918
[TBL] [Abstract][Full Text] [Related]
11. Intratumoral delivery of immunotherapy to treat breast cancer: current development in clinical and preclinical studies.
Mantooth SM; Abdou Y; Saez-Ibañez AR; Upadhaya S; Zaharoff DA
Front Immunol; 2024; 15():1385484. PubMed ID: 38803496
[TBL] [Abstract][Full Text] [Related]
12. Localized delivery of immunotherapeutics: A rising trend in the field.
Wang J; Zhang Y; Pi J; Xing D; Wang C
J Control Release; 2021 Dec; 340():149-167. PubMed ID: 34699871
[TBL] [Abstract][Full Text] [Related]
13. The era of bioengineering: how will this affect the next generation of cancer immunotherapy?
Graciotti M; Berti C; Klok HA; Kandalaft L
J Transl Med; 2017 Jun; 15(1):142. PubMed ID: 28629381
[TBL] [Abstract][Full Text] [Related]
14. Functionalized chitosan as a promising platform for cancer immunotherapy: A review.
Liang X; Mu M; Fan R; Zou B; Guo G
Carbohydr Polym; 2022 Aug; 290():119452. PubMed ID: 35550761
[TBL] [Abstract][Full Text] [Related]
15. Advances in drug delivery for post-surgical cancer treatment.
Bu LL; Yan J; Wang Z; Ruan H; Chen Q; Gunadhi V; Bell RB; Gu Z
Biomaterials; 2019 Oct; 219():119182. PubMed ID: 31415954
[TBL] [Abstract][Full Text] [Related]
16. Tumor immune microenvironment modulation-based drug delivery strategies for cancer immunotherapy.
Han S; Huang K; Gu Z; Wu J
Nanoscale; 2020 Jan; 12(2):413-436. PubMed ID: 31829394
[TBL] [Abstract][Full Text] [Related]
17. Modulating the tumor immune microenvironment with locoregional image-guided interventions.
Jain S; Sheth RA
Front Immunol; 2022; 13():1057597. PubMed ID: 36685505
[TBL] [Abstract][Full Text] [Related]
18. Localized Interleukin-12 for Cancer Immunotherapy.
Nguyen KG; Vrabel MR; Mantooth SM; Hopkins JJ; Wagner ES; Gabaldon TA; Zaharoff DA
Front Immunol; 2020; 11():575597. PubMed ID: 33178203
[TBL] [Abstract][Full Text] [Related]
19. Locally Injectable Hydrogels for Tumor Immunotherapy.
Zhang X; Guo X; Wu Y; Gao J
Gels; 2021 Nov; 7(4):. PubMed ID: 34842684
[TBL] [Abstract][Full Text] [Related]
20. Engineered biomaterials for cancer immunotherapy.
Cai L; Xu J; Yang Z; Tong R; Dong Z; Wang C; Leong KW
MedComm (2020); 2020 Jun; 1(1):35-46. PubMed ID: 34766108
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
